Characteristics and Antibiotic Resistance of Urinary Tract Pathogens Isolated from Indoor Cases of A Tertiary Care Hospital
DOI:
https://doi.org/10.51253/pafmj.v76iSUPPL-9.12252Keywords:
Antimicrobial susceptibility, Urinary tract infections, Urine CulturesAbstract
Objective: To determine the antimicrobial sensitivity of uropathogens among inpatients at a tertiary care hospital in Pakistan.
Study Design: Cross-sectional study
Place and Duration of Study: Pak Emirates Military Hospital, Rawalpindi; Pakistan Apr to Jun 2023.
Methodology: After ethics approval, male and female adult patients from medical wards were included. Non-probability, consecutive sampling was used. Patients with clinical and/ or urinalysis findings of urinary tract infection were included, excluding those unwilling or unable to provide informed consent. Demographic variables and clinical history were collected. 1,339 Urine cultures were sent to the Department of Microbiology, Army Medical College, Rawalpindi. Antimicrobial susceptibility testing was performed via the disc diffusion method for isolates.
Results: The mean age of the participants was 51.00 (34.00-67.00) years with 795(59.37%) females. The most common primary diagnosis was neurological disease (n=177 [13.22%]). Positive growth was identified in 1,294 (96.64%), with 27(2.02%) fungal infections. Of the 1,267 bacterial isolates, 1,055(83.27%) were Gram-negative. Escherichia coli was the most frequently isolated pathogen, with 846 cases (66.78%), followed by Enterococcus faecalis with 178(14.05%). High sensitivity for E. coli was observed for Imipenem (99.44%), Meropenem (98.19%), and Amikacin (97.92%), while Ampicillin (6.73%) and Erythromycin (16.38%) exhibited low sensitivity. E. faecalis exhibited susceptibility to Nitrofurantoin (97.19%) and Fosfomycin (91.57%) but showed lower susceptibility to Ampicillin (38.20%) and doxycycline (17.98%).
Conclusion: Antibiotics exhibiting higher efficacy across various uropathogens should be considered for the first-line empirical treatment for UTIs. Local antimicrobial resistance patterns exist and susceptibility testing is recommended for inpatient UTIs.
Downloads
References
1. Stamm WE, Norrby SR. Urinary tract infections: disease panorama and challenges. J Infect Dis 2001; 183 Suppl 1: S1-S4.
http://dx.doi.org/10.1086/318850
2. Mann R, Mediati DG, Duggin IG, Harry EJ, Bottomley AL. Metabolic Adaptations of Uropathogenic E. coli in the Urinary Tract. Front Cell Infect Microbiol 2017; 7: 241.
http://doi.org/10.3389/fcimb.2017.00241
3. Kaur R, Kaur R. Symptoms, risk factors, diagnosis and treatment of urinary tract infections. Postgrad Med J 2021; 97(1154): 803–812. http://doi.org/10.1136/postgradmedj-2020-139090
4. Sabih A, Leslie SW. Complicated urinary tract infections. StatPearls Publishing; 2023.
5. Paul R. State of the Globe: Rising antimicrobial resistance of pathogens in urinary tract infection. J Glob Infect Dis 2018; 10(3): 117–118. http://dx.doi.org/10.4103/jgid.jgid_104_17
6. Zilberberg MD, Nathanson BH, Sulham K, Shorr AF. Descriptive epidemiology and outcomes of hospitalizations with complicated urinary tract infections in the United States, 2018. Open Forum Infect Dis 2022; 9(1): ofab591.
http://doi.org/10.1093/ofid/ofab591
7. Liu J, Hao X, Shang X, Chi R, Xu T. Incidence and risk factors of urinary tract infection in hospitalized patients with spinal cord injury in a hospital of China. Sci Rep 2024; 14(1): 3579.
http://doi.org/10.1038/s41598-024-54234-2
8. Garcia-Bustos V, Escrig AIR, López CC, Estellés RA, Jerusalem K, Cabañero-Navalón MD, et al. Prospective cohort study on hospitalised patients with suspected urinary tract infection and risk factors por multidrug resistance. Sci Rep 2021; 11(1): 11927.
http://doi.org/10.1038/s41598-021-90949-2
9. Khatoon I, Khanam S, Azam A, Qadeer S, Naz S, Hassan NU. Incidence Pattern, Antibiotic Susceptibility Pattern and Associated Risk Factors of Bacterial Uropathogens Among General Population of Pakistan. Infect Drug Resist 2023; 16: 4995-5005. http://dx.doi.org/10.2147/IDR.S418045
10. Naboka YL, Mavzyutov AR, Kogan MI, Gudima IA, Dzhalagoniya KT, Ivanov SN, et al. The gene profile of Enterobacteriaceae virulence factors in relation to bacteriuria levels between the acute episodes of recurrent uncomplicated lower urinary tract infection. Expert Rev Anti Infect Ther 2021; 19(8): 1061–1066. http://doi.org/10.1080/14787210.2021.1866986
11. Mohamed ES, Khairy RMM, Abdelrahim SS. Prevalence and molecular characteristics of ESBL and AmpC β -lactamase producing Enterobacteriaceae strains isolated from UTIs in Egypt. Antimicrob Resist Infect Control 2020; 9(1).
http://dx.doi.org/10.1186/s13756-020-00856-w
12. Shakya P, Shrestha D, Maharjan E, Sharma VK, Paudyal R. ESBL production among E. coli and Klebsiella spp. Causing urinary tract infection: A hospital based study. Open Microbiol J 2017; 11(1): 23–30. http://dx.doi.org/10.2174/1874285801711010023
13. Naushad VA, Purayil NK, Wilson GJ, Chandra P, Joseph P, Khalil Z, et al. Epidemiology of urinary tract infection in adults caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae - a case-control study from Qatar. IJID Reg 2022; 3: 278–286. http://dx.doi.org/10.1016/j.ijregi.2022.05.001
14. Mohammed I, Abass E. Phenotypic detection of Extended Spectrum β-Lactamases (ESBL) among gram negative uropathogens reveals highly susceptibility to imipenem: Detection of ESBL among gram negative uropathogens. Pak J Med Sci Q 2019; 35(4): 1104–1109.
http://dx.doi.org/10.12669/pjms.35.4.207
15. Abrar S, Hussain S, Khan RA, Ul Ain N, Haider H, Riaz S. Prevalence of extended-spectrum-β-lactamase-producing Enterobacteriaceae: first systematic meta-analysis report from Pakistan. Antimicrob Resist Infect Control 2018; 7(1): 309.
http://dx.doi.org/10.1186/s13756-018-0309-1
16. Habeeb MA, Sarwar Y, Ali A, Salman M, Haque A. Rapid emergence of ESBL producers in E. coli causing urinary and wound infections in Pakistan. Pak J Med Sci Q 2013; 29(2): 540–544. http://dx.doi.org/10.12669/pjms.292.3144
17. Gharavi MJ, Zarei J, Roshani-Asl P, Yazdanyar Z, Sharif M, Rashidi N. Comprehensive study of antimicrobial susceptibility pattern and extended spectrum beta-lactamase (ESBL) prevalence in bacteria isolated from urine samples. Sci Rep 2021; 11(1): 79791. http://doi.org/10.1038/s41598-020-79791-0
18. Mohammed MA, Alnour TMS, Shakurfo OM, Aburass MM. Prevalence and antimicrobial resistance pattern of bacterial strains isolated from patients with urinary tract infection in Messalata Central Hospital, Libya. Asian Pac J Trop Med2016; 9(8): 771–776.
http://dx.doi.org/10.1016/j.apjtm.2016.06.011
19. Shakibaie M. Antimicrobial susceptibility pattern and ESBL production among uropathogenic Escherichia coli isolated from UTI children in pediatric unit of a hospital in Kerman, Iran. Br Microbiol Res J 2014; 4(3): 262–271.
http://dx.doi.org/10.9734/bmrj/2014/6563
20. Koshesh M, Mansouri S, Hashemizadeh Z, Kalantar-Neyestanaki D. Identification of extended-spectrum β-lactamase genes and AmpC-β-lactamase in clinical isolates of Escherichia coli recovered from patients with urinary tract infections in Kerman, Iran. Arch Pediatr Infect Dis 2016 ;5(2): 37968. http://doi.org/10.5812/pedinfect.37968.
21. Khan IU, Mirza IA, Ikram A, Afzal A, Ali S, Hussain A, et al. Antimicrobial susceptibility pattern of bacteria isolated from patients with urinary tract infection. J Coll Physicians Surg Pak 2014; 24(11): 840–844. http://dx.doi.org/11.2014/JCPSP.840844
22. Bangash K, Mumtaz H, Mehmood M, Hingoro MA, Khan ZZ, Sohail A, et al. Twelve-year trend of Escherichia coli antibiotic resistance in the Islamabad population. Ann Med Surg 2022; 78(103855): 103855. http://doi.org/10.1016/j.amsu.2022.103855
23. Sohail M, Khurshid M, Saleem HGM, Javed H, Khan AA. Characteristics and antibiotic resistance of urinary tract pathogens isolated from Punjab, Pakistan. Jundishapur J Microbiol 2015; 8(7): e19272.
http://dx.doi.org/10.5812/jjm.19272v2
24. Khatoon I, Khanam S, Azam A, Qadeer S, Naz S, Hassan NU. Incidence pattern, antibiotic susceptibility pattern and associated risk factors of bacterial uropathogens among general population of Pakistan. Infect Drug Resist 2023; 16: 4995–5005.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Nauman Karim, Salman Saleem, Muhammad Iqbal, Abdul Rehman Arshad, Waleed Ur Rehman, Farrukh Sair

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.





